Discover how the latest breakthroughs in folate receptor alpha (FR )-targeted antibody-drug conjugates (ADCs) are redefining what’s possible with biomarker-driven therapy! From landmark clinical findings to promising next-generation ADCs, new treatment opportunities are expanding care across the entire FR biomarker continuum. Join renowned expert faculty as they unpack the latest clinical evidence, share practical pearls for biomarker testing and treatment sequencing, and provide evidence-based strategies for toxicity management that can be immediately applied to deliver more personalized care for patients with PROC. In this CE Concepts live symposium, expert faculty will review the latest clinical evidence for integrating FR testing into treatment decision-making as well as practical strategies for selecting and sequencing FR -targeted ADCs, including anticipating and managing toxicities, to deliver personalized, multidisciplinary care with greater confidence in the rapidly evolving PROC treatment landscape.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 201 King of Prussia Rd
Pricing
100% of listed courses are free
18 of 18 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
WhenOct 2 – Dec 2, 2026
-
PRIME Education, Inc. (PRIME®) The Next Wave of ADC Innovation in Platinum-Resistant Ovarian Cancer
-
National Ovarian Cancer Coalition +1 Powering Pathology Precision: Expert Strategies for Folate Receptor Alpha Testing to Guide Personalized ADC Care in Advanced Ovarian Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) InterACT ADC Treatment Optimization & Care Team Activation in PROC: Enhancing Multidisciplinary Implementation, Toxicity Mitigation, and Workflow Readiness in Community Practice
-
Creative Educational Concepts, Inc. The FR Frontier: New Pathways in Platinum-Resistant Ovarian Cancer
-
Creative Educational Concepts, Inc. Checkpoint Resistance and Beyond: Unlocking the Promise of Novel IO Agents in mNSCLC
-
Creative Educational Concepts, Inc. AI-Powered Precision Learning: Optimizing Frontline Treatment Decision-Making in Chronic Lymphocytic Leukemia: Integrating Biomarkers, Clinical Evidence, and Patient-Centered Care
